Deal Makers of Japan, Volume 3
The Deal Makers of Japan series aims to bridge the gap and offer insight to a global biopharma audience to the Japanese pharma industry.
Asian Capabilities, Insight, Market Trends, White Papers
2023
Podcast
Biotalk Episode 3: 2023 Q1 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 11:08 — 12.2MB)
Subscribe: Apple Podcasts | Spotify | RSS
This episode of Biotalk is focused on Locust Walk’s 2023 First Quarter Market Conditions Report, in which we apply the latest
Podcast
Biotalk Episode 2: A Conversation with Andrew Allen
Podcast: Play in new window | Download (Duration: 41:12 — 45.4MB)
Subscribe: Apple Podcasts | Spotify | RSS
On this episode of Biotalk, Locust Walk welcomes Andrew Allen, M.D., Ph.D., Co-Founder, President, CEO, and board member of Gritstone
Insight, Market Trends, White Papers
RNA Therapeutics Landscape Overview
While these key pillars are not exhaustive and approaches may overlap between multiple, these areas have seen a great deal of innovation and attention from strategics and investors as a result.
Podcast
Biotalk Episode 1: Expectations for 2023 Biotech Market
Podcast: Play in new window | Download (Duration: 13:12 — 14.7MB)
Subscribe: Apple Podcasts | Spotify | RSS
Our first Biotalk podcast is focused on Locust Walk’s 2022 year-in-review market conditions, which was released the first day of JPMorgan
Insight, Market Conditions, Market Trends, Quarterly Reports
2022 Year-In-Review Report: Global Trends in Biopharma Transactions
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2022 Year In Review Report applies the latest data to analyze current activities in the life sciences deal landscape.